Hospital
Hialeah Hospital INC.
Hialeah Hospital INC. was paid $3.62M by Medicaid between Jan 2018 and Oct 2021, across 158 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 13% of everything it billed.
33Billing provider infoHIALEAH HOSPITAL INC.
HIALEAH, FL 33013
HIALEAH, FL 33013
33aNPI1063442770assigned 07/05/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.62M
24GClaims280,708
24DCodes billed158
24AFirst – last monthJan 2018 – Oct 2021
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#94 of 163
Median peer was paid$4.77M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 41,015 | $584K | |
| 2019 | 119,337 | $1.37M | |
| 2020 | 70,324 | $988K | |
| 2021 | 50,032 | $675K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 13% | 6,737 | 4,235 | $462K |
| 80053 | Comprehensive metabolic panel | 8.2% | 10,465 | 7,206 | $298K |
| 96361 | Intravenous infusion, hydration; each additional hour | 7.1% | 4,048 | 3,448 | $258K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.8% | 10,208 | 8,857 | $248K |
| 80048 | Basic metabolic panel (calcium, ionized) | 6.5% | 6,870 | 5,662 | $236K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.6% | 8,377 | 7,379 | $204K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 3.8% | 2,535 | 2,208 | $136K |
| S0028 | Injection, famotidine, 20 mg | 3.6% | 1,564 | 1,328 | $132K |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 2.9% | 2,474 | 1,154 | $107K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.9% | 6,001 | 4,992 | $105K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.7% | 2,878 | 2,495 | $97K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2.6% | 1,704 | 677 | $94K |
146 more codes
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.6% | 2,383 | $93K |
| J3490 | Unclassified drugs | 2.5% | 595 | $90K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.9% | 2,599 | $69K |
| 81001 | 1.9% | 9,193 | $69K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.9% | 1,262 | $68K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.7% | 1,942 | $61K |
| 84703 | 1.5% | 7,141 | $56K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 1.5% | 1,118 | $54K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 631 | $49K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 1,596 | $40K |
| G0378 | Hospital observation service, per hour | 1.1% | 7,470 | $40K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,157 | $32K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,027 | $31K |
| 59025 | Fetal non-stress test | <1% | 642 | $28K |
| 82962 | <1% | 6,157 | $24K | |
| 71045 | Radiologic examination, chest; single view | <1% | 8,718 | $23K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 17,424 | $22K |
| 81003 | <1% | 2,447 | $21K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,628 | $18K |
| 87070 | <1% | 1,944 | $18K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 991 | $17K |
| A9270 | Non-covered item or service | <1% | 3,836 | $17K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,732 | $17K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,694 | $15K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 437 | $13K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 876 | $13K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,447 | $12K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,732 | $12K |
| J1815 | Injection, insulin, per 5 units | <1% | 537 | $12K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,746 | $11K |
| 84484 | <1% | 6,317 | $10K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 209 | $10K |
| 84702 | <1% | 2,537 | $8K | |
| 85610 | <1% | 6,472 | $8K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 52 | $8K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 6,963 | $7K |
| 85730 | <1% | 5,563 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 739 | $7K |
| 72131 | <1% | 359 | $6K | |
| 87040 | <1% | 3,448 | $6K | |
| S0030 | Injection, metronidazole, 500 mg | <1% | 409 | $6K |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 1,656 | $5K |
| 82550 | <1% | 4,311 | $4K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 914 | $4K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 989 | $4K |
| 80076 | <1% | 1,687 | $4K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,099 | $4K |
| 84112 | <1% | 26 | $4K | |
| 76830 | Ultrasound, transvaginal | <1% | 157 | $4K |
| J0456 | Injection, azithromycin, 500 mg | <1% | 121 | $3K |
| 83690 | <1% | 2,880 | $3K | |
| 73562 | <1% | 173 | $3K | |
| 83605 | <1% | 2,321 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,494 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,093 | $3K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,554 | $3K |
| 83880 | <1% | 1,775 | $3K | |
| 73030 | <1% | 303 | $3K | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 508 | $3K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 424 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,038 | $2K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,247 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 228 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,323 | $2K |
| 76818 | <1% | 94 | $2K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 130 | $2K |
| 86900 | <1% | 1,991 | $2K | |
| 86850 | <1% | 1,622 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,861 | $2K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 571 | $2K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,453 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 827 | $2K |
| 87077 | <1% | 1,301 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,559 | $2K |
| 90715 | <1% | 328 | $2K | |
| 71250 | <1% | 201 | $2K | |
| 73610 | <1% | 169 | $1K | |
| 73130 | <1% | 70 | $1K | |
| 94664 | <1% | 880 | $1K | |
| 87186 | <1% | 1,298 | $1K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 959 | $1K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 26 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 268 | $1K |
| 82803 | <1% | 850 | $1K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 814 | $1K |
| 86901 | <1% | 1,992 | $1K | |
| 73630 | <1% | 185 | $1K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 537 | $982.09 |
| 87205 | <1% | 270 | $960.72 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,985 | $872.16 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,112 | $844.72 |
| 93971 | <1% | 79 | $754.49 | |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | <1% | 83 | $595.18 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 859 | $569.39 |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 116 | $558.20 |
| 76801 | <1% | 147 | $532.05 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 129 | $394.86 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 664 | $393.07 |
| J1956 | Injection, levofloxacin, 250 mg | <1% | 323 | $389.12 |
| 73110 | <1% | 49 | $385.76 | |
| 76775 | <1% | 25 | $384.67 | |
| 93970 | <1% | 67 | $314.57 | |
| 97597 | <1% | 23 | $278.58 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 851 | $213.59 |
| 83735 | <1% | 1,624 | $209.10 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,156 | $200.54 |
| 85379 | <1% | 539 | $196.20 | |
| 84100 | <1% | 1,430 | $191.26 | |
| 97163 | <1% | 65 | $191.09 | |
| 36410 | <1% | 59 | $131.48 | |
| 74018 | <1% | 42 | $128.74 | |
| 82150 | <1% | 368 | $108.58 | |
| 93880 | <1% | 33 | $98.64 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 27 | $96.84 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 14 | $90.91 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 298 | $81.46 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 116 | $59.78 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 29 | $41.91 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 711 | $30.91 |
| 80061 | Lipid panel | <1% | 196 | $25.36 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 744 | $17.36 |
| 86592 | <1% | 16 | $7.51 | |
| 87807 | <1% | 152 | $4.91 | |
| 86140 | <1% | 117 | $2.88 | |
| 70486 | <1% | 15 | $2.40 | |
| 88304 | <1% | 123 | $2.32 | |
| 87210 | <1% | 15 | $1.92 | |
| 87320 | <1% | 14 | $1.44 | |
| 87081 | <1% | 15 | $1.44 | |
| 83615 | <1% | 76 | $0.96 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 30 | $0.96 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 15 | $0.92 |
| 82728 | <1% | 134 | $0.48 | |
| 73564 | <1% | 21 | $0.46 | |
| 97166 | 0% | 13 | $0.00 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 28 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 13 | $0.00 |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 0% | 17 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 24 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 17 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 49 | $0.00 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 0% | 95 | $0.00 |
| 88312 | 0% | 45 | $0.00 | |
| 99218 | 0% | 62 | $0.00 | |
| 84145 | 0% | 18 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialARMIN, CRAIG (VP OF GOVT PROGRAMS, TENET)
| Provider | Location | Paid |
|---|---|---|
| Lifemark Hospitals of Florida, INC. | Hialeah, FL | $7.11M |
| North Shore Medical Center, INC. | Miami, FL | $4.42M |
| North Shore Medical Center, INC. | Lauderdale Lakes, FL | $2.52M |
| CGH Hospital, LTD. | Coral Gables, FL | $1.67M |
| VHS West Suburban Medical Center INC | Oak Park, IL | $1.46M |
| VHS Westlake Hospital INC | Melrose Park, IL | $326K |
| Tenet Healthsystem ST. Christopher's Hospital for Children, LLC | Philadelphia, PA | $22K |
| FMC Hospital, LTD. | Lauderdale Lakes, FL | $4K |
| San Dimas Community Hospital, INC. | San Dimas, CA | $963.01 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.